Your browser doesn't support javascript.
loading
Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer.
Chiang, Cho-Han; Chiang, Cho-Hung; Chiang, Cho-Hsien; Ma, Kevin Sheng-Kai; Peng, Chun-Yu; Hsia, Yuan Ping; Horng, Chuan-Sheng; Chen, Cheng-Ying; Chang, Yu-Cheng; See, Xin Ya; Chen, Yuan-Jen; Wang, Shih-Syuan; Suero-Abreu, Giselle A; Peterson, L R; Thavendiranathan, Paaladinesh; Armand, Philippe; Peng, Cheng-Ming; Shiah, Her-Shyong; Neilan, Tomas G.
Afiliación
  • Chiang CH; Department of Medicine, Mount Auburn Hospital, Cambridge, Massachusetts, USA b02401124@ntu.edu.tw.
  • Chiang CH; Department of General Division, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Foundation, Taipei, Taiwan.
  • Chiang CH; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Ma KS; Department of Medical Education, Kuang Tien General Hospital, Taichung, Taiwan.
  • Peng CY; London School of Hygiene & Tropical Medicine, London, UK.
  • Hsia YP; Center for Global Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Horng CS; Department of Epidemiology, Harvard University T H Chan School of Public Health, Boston, Massachusetts, USA.
  • Chen CY; Department of Medicine, Danbury Hospital, Danbury, Connecticut, USA.
  • Chang YC; Department of Family Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Foundation, Taipei, Taiwan.
  • See XY; Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Chen YJ; Department of Medical Education, Cathay General Hospital, Taipei, Taiwan.
  • Wang SS; Da Vinci Minimally Invasive Surgery Center, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Suero-Abreu GA; Department of Medicine, Unity Hospital, Rochester Regional Health, Rochester, New York, USA.
  • Peterson LR; Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Thavendiranathan P; Da Vinci Minimally Invasive Surgery Center, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Armand P; Cardio-Oncology Program, Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Peng CM; Department of Medicine and Radiology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.
  • Shiah HS; Ted Rogers Program in Cardiotoxicity Prevention, Peter Munk Cardiac Center, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Neilan TG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Heart ; 109(6): 470-477, 2023 02 23.
Article en En | MEDLINE | ID: mdl-36351793
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Insuficiencia Cardíaca / Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Heart Asunto de la revista: CARDIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Insuficiencia Cardíaca / Neoplasias Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Heart Asunto de la revista: CARDIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido